6月28日,第一三共(中国)宣布,旗下自主研发的创新药物德力静®(苯磺酸美洛加巴林片,英文商品名: TARLIGE®)获国家药品监督管理局批准,用于治疗成人糖尿病性周围神经病理性疼痛。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.